Amarin Corporation plc ( AMRN) - Stock Earnings
AMRN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 29, 2026, midnight | — / — | — | — / — | — |
AMRN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -7.7 million USD | 49.7 million USD |
| 2025Q4 | -1.2 million USD | 49.1 million USD |
| 2026Q1 | -10.5 million USD | 43.3 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
AMRN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -59.1 million USD | 306.9 million USD |
| 2024 | -82.2 million USD | 228.6 million USD |
| 2025 | -38.8 million USD | 213.6 million USD |
| 2026 Est. | — | — |
AMRN
Price: $13.71
Earnings Per Share: -1.60 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Ireland
Volume: 2.2 million
Ebitda: -8.2 millionMarket Capitalization: 338.6 million